Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective.

Tcheng, J E

Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective. [electronic resource] - The American journal of cardiology Aug 1996 - 35-40 p. digital

Publication Type: Journal Article; Review

0002-9149

10.1016/s0002-9149(96)00490-0 doi


Abciximab
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal--therapeutic use
Atherectomy, Coronary
Constriction, Pathologic
Eptifibatide
Humans
Immunoglobulin Fab Fragments--therapeutic use
Peptides--therapeutic use
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Randomized Controlled Trials as Topic
Recurrence
Stents
Tirofiban
Treatment Outcome
Tyrosine--analogs & derivatives